Article info

Original research
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells

Authors

  1. Correspondence to Megen C Wittling; megen.wittling{at}emory.edu; Dr. Gregory B Lesinski; gregory.b.lesinski{at}emory.edu; Dr. Chrystal M Paulos; chrystal.mary.paulos{at}emory.edu
View Full Text

Citation

Wittling MC, Knochelmann HM, Wyatt MM, et al
Distinct host preconditioning regimens differentially impact the antitumor potency of adoptively transferred Th17 cells

Publication history

  • Accepted June 2, 2024
  • First published June 30, 2024.
Online issue publication 
June 30, 2024
  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.